Evaluation of Dose-Intense Ifosfamide, with and Without Edatrexate, in Adults with Sarcoma

Purpose. To define the maximally tolerated dose (MTD) of ifosfamide when given with G-CSF on an every other week schedule, and to define the MTD of edatrexate that can be given every two weeks with an intense schedule of ifosfamide. Patients and Methods. Forty-one patients with metastatic or unresec...

Descripción completa

Detalles Bibliográficos
Autores principales: Casper, Ephraim S., Schwartz, Gary M., Leung, Denis, Sugarman, Alison, Bertino, Joseph R.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1999
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395414/
https://www.ncbi.nlm.nih.gov/pubmed/18521274
http://dx.doi.org/10.1080/13577149977758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395414/
https://www.ncbi.nlm.nih.gov/pubmed/18521274
http://dx.doi.org/10.1080/13577149977758

Ejemplares similares